The Cleveland Plain Dealer reported that the FDA “recently told the makers of Singulair and three less widely used asthma drugs — Accolate, Zyflo and Zyflo CR — that the drugs’ labels must list a dozen mood and behavior changes as possible side effects.” The article focuses on a group of mothers who had pushed for the warning. “The group’s goal now is to get a ‘black box’ warning for Singulair.”
From the American Association for Justice news release.